165 related articles for article (PubMed ID: 32120375)
1. Evaluation of inflammatory bowel disease activity in children using serum trefoil factor peptide.
Teng X; Yang Y; Liu L; Yang L; Wu J; Sun M; Xu L
Pediatr Res; 2020 Nov; 88(5):792-795. PubMed ID: 32120375
[TBL] [Abstract][Full Text] [Related]
2. Serum trefoil factor 3 predicts disease activity in patients with ulcerative colitis.
Nakov R; Velikova T; Nakov V; Ianiro G; Gerova V; Tankova L
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):788-794. PubMed ID: 30720187
[TBL] [Abstract][Full Text] [Related]
3. Serum human trefoil factor 3 is a biomarker for mucosal healing in ulcerative colitis patients with minimal disease activity.
Srivastava S; Kedia S; Kumar S; Pratap Mouli V; Dhingra R; Sachdev V; Tiwari V; Kurrey L; Pradhan R; Ahuja V
J Crohns Colitis; 2015 Jul; 9(7):575-9. PubMed ID: 25964429
[TBL] [Abstract][Full Text] [Related]
4. Trefoil Factor 3 is Highly Predictive of Complete Mucosal Healing Independently and in Combination with C-Reactive Protein in Patients with Ulcerative Colitis.
Nakov R; Velikova T; Nakov V; Gerova V; Tankova L
J Gastrointestin Liver Dis; 2019 Jun; 28():169-174. PubMed ID: 31204414
[TBL] [Abstract][Full Text] [Related]
5. Systemic interleukin-9 in inflammatory bowel disease: Association with mucosal healing in ulcerative colitis.
Matusiewicz M; Neubauer K; Bednarz-Misa I; Gorska S; Krzystek-Korpacka M
World J Gastroenterol; 2017 Jun; 23(22):4039-4046. PubMed ID: 28652656
[TBL] [Abstract][Full Text] [Related]
6. Is ischemia modified albumin a disease activity marker for inflammatory bowel diseases?
Kaplan M; Yuksel M; Ates I; Kilic ZM; Kilic H; Kuzu UB; Kayacetin E
J Gastroenterol Hepatol; 2016 Jun; 31(6):1120-5. PubMed ID: 26642816
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
[TBL] [Abstract][Full Text] [Related]
8. Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing.
Chang J; Leong RW; Wasinger VC; Ip M; Yang M; Phan TG
Gastroenterology; 2017 Sep; 153(3):723-731.e1. PubMed ID: 28601482
[TBL] [Abstract][Full Text] [Related]
9. Serum trefoil factors in patients with inflammatory bowel disease.
Grønbaek H; Vestergaard EM; Hey H; Nielsen JN; Nexø E
Digestion; 2006; 74(1):33-9. PubMed ID: 17068395
[TBL] [Abstract][Full Text] [Related]
10. Sepsis Markers Soluble IL-2 Receptor and Soluble CD14 Subtype as Potential Biomarkers for Complete Mucosal Healing in Patients With Inflammatory Bowel Disease.
Hosomi S; Yamagami H; Itani S; Yukawa T; Otani K; Nagami Y; Tanaka F; Taira K; Kamata N; Tanigawa T; Shiba M; Watanabe T; Fujiwara Y
J Crohns Colitis; 2018 Jan; 12(1):87-95. PubMed ID: 28961693
[TBL] [Abstract][Full Text] [Related]
11. GlycA, a Nuclear Magnetic Resonance Spectroscopy Measure for Protein Glycosylation, is a Viable Biomarker for Disease Activity in IBD.
Dierckx T; Verstockt B; Vermeire S; van Weyenbergh J
J Crohns Colitis; 2019 Mar; 13(3):389-394. PubMed ID: 30312386
[TBL] [Abstract][Full Text] [Related]
12. Are faecal markers good indicators of mucosal healing in inflammatory bowel disease?
Boon GJ; Day AS; Mulder CJ; Gearry RB
World J Gastroenterol; 2015 Oct; 21(40):11469-80. PubMed ID: 26523111
[TBL] [Abstract][Full Text] [Related]
13. Correlation Between Anti-TNF Serum Levels and Endoscopic Inflammation in Inflammatory Bowel Disease Patients.
Chaparro M; Barreiro-de Acosta M; Echarri A; Almendros R; Barrio J; Llao J; Gomollón F; Vera M; Cabriada JL; Guardiola J; Guerra I; Beltrán B; Roncero O; Busquets D; Taxonera C; Calvet X; Ferreiro-Iglesias R; Ollero Pena V; Bernardo D; Donday MG; Garre A; Godino A; Díaz A; Gisbert JP
Dig Dis Sci; 2019 Mar; 64(3):846-854. PubMed ID: 30426297
[TBL] [Abstract][Full Text] [Related]
14. Mucosal Expression of Type 2 and Type 17 Immune Response Genes Distinguishes Ulcerative Colitis From Colon-Only Crohn's Disease in Treatment-Naive Pediatric Patients.
Rosen MJ; Karns R; Vallance JE; Bezold R; Waddell A; Collins MH; Haberman Y; Minar P; Baldassano RN; Hyams JS; Baker SS; Kellermayer R; Noe JD; Griffiths AM; Rosh JR; Crandall WV; Heyman MB; Mack DR; Kappelman MD; Markowitz J; Moulton DE; Leleiko NS; Walters TD; Kugathasan S; Wilson KT; Hogan SP; Denson LA
Gastroenterology; 2017 May; 152(6):1345-1357.e7. PubMed ID: 28132889
[TBL] [Abstract][Full Text] [Related]
15. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-320a Monitors Intestinal Disease Activity in Patients With Inflammatory Bowel Disease.
Cordes F; Demmig C; Bokemeyer A; Brückner M; Lenze F; Lenz P; Nowacki T; Tepasse P; Schmidt HH; Schmidt MA; Cichon C; Bettenworth D
Clin Transl Gastroenterol; 2020 Mar; 11(3):e00134. PubMed ID: 32352717
[TBL] [Abstract][Full Text] [Related]
17. ATF4 Deficiency Promotes Intestinal Inflammation in Mice by Reducing Uptake of Glutamine and Expression of Antimicrobial Peptides.
Hu X; Deng J; Yu T; Chen S; Ge Y; Zhou Z; Guo Y; Ying H; Zhai Q; Chen Y; Yuan F; Niu Y; Shu W; Chen H; Ma C; Liu Z; Guo F
Gastroenterology; 2019 Mar; 156(4):1098-1111. PubMed ID: 30452920
[TBL] [Abstract][Full Text] [Related]
18. [Inflammatory bowel disease in children--an analysis of the clinical symptoms and selected biochemical parameters].
Landowski P; Liberek A; Szlagatys-Sidorkiewicz A; Radys W; Brodzicki J; Szarszewski A; Marek A; Łuczak G; Kamińska B
Med Wieku Rozwoj; 2007; 11(4):401-7. PubMed ID: 18605192
[TBL] [Abstract][Full Text] [Related]
19. Relationship between levels of angiogenic and lymphangiogenic factors and the endoscopic, histological and clinical activity, and acute-phase reactants in patients with inflammatory bowel disease.
Algaba A; Linares PM; Fernández-Contreras ME; Ordoñez A; Trápaga J; Guerra I; Chaparro M; de la Poza G; Gisbert JP; Bermejo F
J Crohns Colitis; 2013 Dec; 7(11):e569-79. PubMed ID: 23642997
[TBL] [Abstract][Full Text] [Related]
20. Serum Interleukin-33 level in Saudi children with inflammatory bowel disease.
Saadah OI; Al-Harthi SE; Al-Mughales JA; Bin-Taleb YY; Baeshen RS
Int J Clin Exp Pathol; 2015; 8(12):16000-6. PubMed ID: 26884875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
